Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: J Cardiovasc Comput Tomogr. 2023 Jan 18;17(2):112–119. doi: 10.1016/j.jcct.2022.12.002

Sex differences in computed tomography angiography-derived coronary plaque burden in relation to invasive fractional flow reserve

Donghee Han 1, Pepijn van Diemen 2, Keiichiro Kuronuma 1, Andrew Lin 3, Manish Motwani 4, Priscilla McElhinney 3, Guadalupe Flores Tomasino 3, Caroline Park 3, Alan Kwan 1, Evangelos Tzolos 1,5, Eyal Klein 1, Kajetan Grodecki 3, Benjamin Shou 3, Balaji Tamarappoo 1,6, Sebastien Cadet 1, Ibrahim Danad 2, Roel S Driessen 2, Daniel S Berman 1, Piotr J Slomka 7, Damini Dey 3,*, Paul Knaapen 2,*
PMCID: PMC10148895  NIHMSID: NIHMS1866852  PMID: 36670043

Abstract

Background

Distinct sex-related differences exist in coronary artery plaque burden and distribution. We aimed to explore sex differences in quantitative plaque burden by coronary CT angiography (CCTA) in relation to ischemia by invasive fractional flow reserve (FFR).

Methods

This post-hoc analysis of the PACIFIC trial included 581 vessels in 203 patients (mean age 58.1 ± 8.7 years, 63.5% male) who underwent CCTA and per-vessel invasive FFR. Quantitative assessment of total, calcified, non-calcified, and low-density non-calcified plaque burden were performed using semiautomated software. Significant ischemia was defined as invasive FFR ≤0.8.

Results

The per-vessel frequency of ischemia was higher in men than women (33.5% vs. 7.5%, p<0.001). Women had a smaller burden of all plaque subtypes (all p<0.01). There was no sex difference on total, calcified, or non-calcified plaque burdens in vessels with ischemia; only low-density non-calcified plaque burden was significantly lower in women (beta: −0.183, p=0.035). The burdens of all plaque subtypes were independently associated with ischemia in both men and women (For total plaque burden (5% increase): Men, OR: 1.15, 95%CI: 1.06-1.24,p=0.001; Women, OR: 1.96,95%CI: 1.11-3.46,p=0.02). No significant interaction existed between sex and total plaque burden for predicting ischemia (interaction p=0.108). The addition of quantitative plaque burdens to stenosis severity and adverse plaque characteristics improved the discrimination of ischemia in both men and women.

Conclusions

In symptomatic patients with suspected CAD, women have a lower CCTA-derived burden of all plaque subtypes compared to men. Quantitative plaque burden provides independent and incremental predictive value for ischemia, irrespective of sex.

Keywords: quantitative plaque analysis, fractional flow reserve, sex difference, computed tomography

TOC summary

We aimed to explore sex differences in quantitative plaque burden by coronary CT angiography in relation to ischemia by invasive fractional flow reserve (FFR). Compared to men, women had lower stenosis severity, fewer adverse plaque characteristics, lower quantitatively plaque burden and fewer abnormal FFR. In multivariable linear regression analysis, there was no sex difference on total, calcified, or non-calcified plaque burdens in vessels with ischemia; only low-density non-calcified plaque burden was significantly lower in women (beta: −0.183, p=0.035). The addition of quantitative plaque burden to stenosis severity and adverse plaque characteristics improved the discrimination of ischemia irrespective of sex.

1. Introduction

Invasive fractional flow reserve (FFR), used to evaluate the functional significance of coronary artery stenosis 1, is considered the gold standard for detection of lesion-specific ischemia. Prior studies have reported sex-related differences in FFR 2, 3, with angiographic lesions of similar stenosis severity being less likely to cause ischemia in women than in men 46.

Coronary CT angiography (CCTA) enables the assessment of the atherosclerotic burden in the entire coronary tree, which has prognostic importance in patients with stable coronary artery disease (CAD) 79. Further, the quantitative burden of total plaque and its various subtypes have been shown to improve the identification of lesion-specific ischemia 1013.

Prior studies have reported distinct sex-related differences in CCTA-derived quantitative plaque characteristics 1417. While women generally exhibit fewer adverse plaque characteristics (APCs) and lower quantitative plaque burdens, the relative risk of adverse cardiovascular outcomes according to CCTA plaque characteristics is higher in women than in men17, 18. Despite this, the sex-specific associations of coronary plaque burden and FFR-defined ischemia have not been explored. In the current study, we aimed to evaluate the impact of sex on CCTA-derived quantitative plaque burden and invasive FFR.

2. Methods

2.1. Study population

The present study was conducted as a post hoc substudy from PACIFIC (Prospective Comparison of Cardiac PET/CT, SPECT/CT Perfusion Imaging and CT Coronary Angiography With Invasive Coronary Angiography; NCT01521468) trial 19. A total of 208 consecutive patients with suspected stable CAD prospectively underwent CCTA and invasive FFR within a 2-week interval. The trial was approved by the institutional ethics committee and all participants provided written informed consent. Among 208 patients, we excluded five patients with suboptimal image quality for the quantitative plaque analysis. Hence, the current study included 203 patients.

2.2. CCTA acquisition

All patients underwent CCTA using a 256-slice CT scanner (Philips Brilliance iCT, Philips Healthcare, Best, the Netherlands). CCTA acquisition parameters were as follows: collimation 128 × 0.625 mm, gantry rotation 270ms, tube current 200-360 mA (according to body mass index), and tube voltage 120 kV. Prior to scanning, sublingual nitroglycerine was administered to all patients and metoprolol as required, aiming for a heart rate less than 65 beats/min. An intravenous bolus of 100ml of iodinated contrast was injected at 5.7 ml/s. The scan was triggered using an automatic bolus-tracking technique with a region of interest placed in the descending thoracic aorta. Prospective electrocardiogram gating was performed at 75% of the R-R interval.

2.3. CCTA: Qualitative analysis

CCTA analysis was performed by an independent core laboratories (St. Paul’s Hospital, Vancouver, British Columbia, Canada, and the Dalio Institute of Cardiovascular Imaing, New York-Presbyterian Hospital, New York) for the assessment of diameter stenosis severity blinded to invasive physiological results. The coronary tree was evaluated according to a 17-segment coronary artery model. All coronary segments ≥2 mm in diameter were visually graded, and classified as no CAD (0% stenosis), minimal CAD (1-24% stenosis), mild CAD (25-49% stenosis), moderate CAD (50-69% stenosis), and severe CAD (70-100% stenosis).

Coronary lesions were qualitatively assessed for the presence of four APCs by an experienced reader (RSD) blinded to clinical and FFR data. The positive remodeling was defined as remodeling index >1.120. Low attenuation plaque was defined as a plaque containing any voxel <30 HU 20. Spotty calcification was defined by a calcified plaque comprising <90° of the vessel circumference and <3 mm in length 20. The napkin ring sign was defined by a plaque with a central area of low CT attenuation surrounded by a rim-like area of higher CT attenuation 21. High risk plaque was defined as presence of two or more APCs.22

2.4. CCTA: Quantitative analysis

Standardized plaque quantification was performed using semiautomated software (Autoplaque v2.5, Cedars-Sinai Medical Center)7, 23 by expert readers (DH, AL, PM, GFT, AK, ET, EK) blinded to clinical and FFR data. The proximal and distal limits of individual coronary lesions were defined by the expert reader. Contouring of the vessel wall and lumen was automatic, with manual adjustment as required by expert reader. The absolute volumes (mm3) of total plaque, calcified plaque, non-calcified plaque, and low-density non-calcified plaque were semi-automatically quantified using adaptive scan-specific thresholds, as previously described.7, 23 The respective plaque burdens (%) were calculated as: plaque volume / analyzed vessel volume × 100.

2.5. Invasive coronary angiography and fractional flow reserve measurements

Invasive coronary angiography was performed according to standard catheterization procedures 24. To induce maximal coronary hyperemia, adenosine was infused by either intravenous or intracoronary adenosine at a dose of 140 μg·kg-1·min-1 or 150 μg, respectively. FFR was calculated as the ratio of the mean distal intracoronary pressure, measured by the pressure wire and the mean arterial pressure measured by the coronary catheter.1 All major coronary arteries were routinely interrogated by FFR, regardless of stenosis severity, except for occluded or subtotal lesions of more than 90%. A coronary lesion was considered hemodynamically significant in case of FFR≤0.80, or stenosis severity >90% obtained with quantitative coronary angiography in case of missing FFR. A stenosis with an FFR >0.80 or a stenosis severity <30% (obtained with quantitative coronary angiography) in the absence of FFR measurements was considered not to be functionally relevant. 2 In per-patient analysis, the lowest FFR among the left anterior descending (LAD), left circumflex (LCX), and right coronary (RCA) arteries was used.

2.6. Statistical Analysis

Continuous variables are represented as mean ± SD and categorical variables as numbers (percentages). The differences between groups were analyzed using Student’s t-test or Mann-Whitney U test for continuous variables and Chi-square test for categorical variables. FFR values were categorized as <0.7, 0.7-0.79, 0.8-0.89, and 0.9-1. Abnormal FFR was defined as FFR≤0.8. The relationship between sex and plaque burden was assessed using multivariable linear regression analysis after adjustment for coronary artery territory distribution (e.g. LAD, LCX or RCA), stenosis severity and APC, with reporting of beta coefficients (β) and standard errors (SE). The statistical significance of the beta coefficients (β) of the female sex was assessed using the likelihood ratio test.25 Multivariable logistic regression analyses reporting odds ratios (OR) with 95 % confidence intervals (95 % CI) were performed to estimate the likelihood of having abnormal FFR in men and women seperately after adjustement for stenosis severity, APCs, and coronary artery distribution. Backward stepwise logistic regression was performed to examine the potential relationship of clinical and imaging parameters with abnormal FFR. In order to account for within-patient correlation, clustered sandwich estimator models were employed. Global chi square analysis was used to assess the incremental value of CCTA-derived quantitative plaque burden for predicting ischemia using three nested models: 1) visual diameter stenosis categories (0%, 1-24%, 25-49%, 50-69%, and 70-100%); 2) model 1 + APCs (positive remodeling, low attenuation plaque, spotty calcification, napkin ring sign); 3) model 2 + quantitative plaque burden (total, calcified, non-calcified and low-density non-calcifieid plaque burden). In addition, we performed a sub-analysis to explore the additive value of APCs over and above the plaque burden (visual stenosis vs. visual stenosis + plaque burden vs. visual stenosis + plaque burden + APCs).

Statistical analyses were performed using STATA (version 17; StataCorp, College Station, TX, USA).

3. Results

3.1. Baseline characteristics

The mean age of the study population was 58.1±8.7, and 73 (36%) were women. Differences in baseline clinical and CT characteristics between men and women are shown in Table 1. Age and the frequency of conventional risk factors did not differ between men and women. Women presented with more atypical or non-specific angina, and men presented with more typical angina. 61% and 28.1% of the total population had moderate and severe stenosis, respectively. The proportion of patients with moderate and severe stenosis were higher in men. The frequency of APCs, including PR, LAP, and SC were lower in women than in men. Likewise, women had smaller all types of plaque volume and burden compared to men (all p<0.01).

Table 1.

Baseline characteristics of study population

Overall Women (n=73) Men (n=130) p-value
Age 58.1±8.7 59.5±9.3 57.4±8.4 0.098
Body mass index 26.9±3.6 26.7±3.8 27.0±3.5 0.688
Diabetes 31 (15.3) 11 (15.1) 20 (15.4) 0.952
Hypertension 93 (45.8) 40 (54.8) 53 (40.8) 0.054
Dyslipidemia 79 (38.9) 29 (39.7) 50 (38.5) 0.859
Current smoking 38 (18.7) 10 (13.7) 28 (21.5) 0.169
Angina Status 0.007
 Typical 70 (34.5) 15 (20.6) 55 (42.3)
 Atypical 76 (37.4) 33 (45.2) 43 (33.1)
 Nonspecific 57 (28.1) 25 (34.3) 32 (24.6)
Medication use
 Aspirin 176 (86.7) 58 (79.5) 118 (90.8) 0.023
 Statin 156 (76.9) 55 (75.3) 101 (77.7) 0.703
 Beta blocker 130 (64.0) 41 (56.2) 89 (68.5) 0.080
 Calcium channel blocker 60 (29.6) 22 (30.1) 38 (29.2) 0.892
 RAAS inhibitor 73 (36.0) 30 (41.1) 43 (33.1) 0.253
 Nitrates 21 (10.4) 10 (13.7) 11 (8.5) 0.247
CACS 176 (19–488) 44 (0–249) 314.5 (69–607) <0.001
 0 36 (17.7) 21 (28.9) 15 (11.5) <0.001
 1–99 48 (23.7) 22 (30.1) 26 (20.0)
 100–399 55 (27.1) 19 (26.0) 36 (27.7)
 >=400 64 (31.5) 11 (15.1) 53 (40.8)
CT stenosis 0.005
 No stenosis 20 (9.9) 10 (13.7) 10 (7.7)
 1–24% 30 (14.8) 16 (21.9) 14 (10.8)
 24–49% 29 (14.3) 14 (19.2) 15 (11.5)
 50–69% 67 (33.0) 22 (30.1) 45 (34.6)
 ≥70% 57 (28.1) 11 (15.1) 46 (35.4)
APCs
 PR 46 (23) 7 (9.9) 39 (30.2) 0.001
 LAP 58 (29) 10 (14.1) 48 (37.2) 0.001
 SC 28 (14) 4 (5.6) 24 (18.6) 0.011
 NRS 19 (9.5) 3 (4.2) 16 (12.4) 0.059
 HRP (≥2 APCs) 45 (22.5) 6 (8.5) 39 (30.2) <0.001
Quantitative plaque characteristics
Total plaque volume, mm3 454.3 (133.6–982.3) 215.1 (41.7–439.6) 713.7 (233.2–1162.4) <0.001
 Calcified plaque 62.1 (5.2–135.5) 13.9 (0–79.8) 91.8 (13.6–171.8) <0.001
 Non-calcified plaque 372.4 (117.3–811.6) 163.8 (36.8–352.8) 568.1 (196.8–1003.3) <0.001
 Low-density plaque 48.9 (14.2–128.7) 22.8 (4.4–48.5) 84.4 (30.4–171.4) <0.001
Total plaque burden, % 49.3 (40.5–55.1) 43.3 (29.8–51.4) 51.0 (45.8–57.4) <0.001
 Calcified plaque 5.2 (1.4–9.9) 3.7 (0–7.6) 6.1 (2.2–11.4) 0.006
 Non-calcified plaque 41.0 (31.9–47.4) 34.9 (23.2–43.9) 43.1 (33.8–48.6) <0.001
 Low-density plaque 5.7 (3.3–8.4) 4.0 (1.8–6.4) 6.7 (3.9–8.9) <0.001

Values are mean standard deviation, median (interquartile ranges) or number (percentage)

Abbreviations: RAAS, renin-angiotensin-aldosterone system; CACS, coronary artery calcium score; PR, positive remodeling; LAP, low attenuation plaque; SC, spotty calcification; NRS, napkin ring sign; HRP, high risk plaque; APC, Adverse plaque characteristics

3.2. Per-patient and per-vessel FFR values

Per-patient and per-vessel FFR results are shown in Table 2. Of the total 203 patients, 85 patients had an FFR ≤0.8 (41.9%). The mean FFR value was 0.87±0.13 in women and 0.75±0.19 in men. The frequency of ischemia was lower in women compared to men (16.4% vs. 56.2%). In per-vessel analysis, FFR values were significantly higher in women compared to men (0.93±0.1 vs. 0.86±0.16, p<0.001). This finding was consistent across all epicardial coronary arteries. Figure 1 shows the frequency of abnormal FFR according to stenosis severity. For vessels with minimal, mild, and moderate stenosis, women had lower frequency of abnormal FFR compared to men. The frequency of abnormal FFR did not differ significantly between men and women in vessels with severe stenosis.

Table 2.

Per-patient and per-vessel FFR results

A. Per patient
Total (n=203) Women (n=73) Men (n=130) p-value
FFR 0.79±0.18 0.87±0.13 0.75±0.19 <0.001
Frequency of abnormal FFR in ≥1 vessels 85 (41.9) 12 (16.4) 73 (56.2) <0.001
LAD 72 (37.5) 10 (14.1) 62 (51.2) <0.001
LCX 30 (15.8) 3 (4.3) 27 (22.5) 0.001
RCA 34 (17.8) 3 (4.2) 31 (25.8) <0.001
B. Per vessel
Total (n=581) Women (n=214) Men (n=367) p-value
FFR 0.89±0.14 0.93±0.10 0.86±0.16 <0.001
Frequency of abnormal FFR 139 (23.9) 16 (7.5) 123 (33.5) <0.001
LAD 0.81±0.17 0.87±013 0.77±0.17 <0.001
LCX 0.93±0.11 0.96±0.06 0.91±0.13 0.003
RCA 0.92±0.12 0.95±0.08 0.90±0.13 0.004

Values are mean standard deviation or number (percentage)

Abbreviations: FFR, fractional flow reserve; LAD, left anterior descending artery; LCX, left circumflex artery; RCA, right coronary artery

Figure 1.

Figure 1.

Per-vessel frequency of abnormal FFR according to degree of stenosis

Abbreviations: FFR, fractional flow reserve

3.3. Quantitative plaque burden and ischemia

The distribution of plaque volume according to subtypes is shown in Figure 2. While lower FFR values were associated with higher plaque volumes in both women and men, women had lower plaque volumes than men across all FFR categories, even in vessels without significant ischemia (FFR>0.8). Overall, per-vessel burdens of total plaque and all plaque subtypes were also lower in women compared to men (Table 3A). Even after adjustment for coronary artery territory, stenosis severity, and APCs, female sex was significantly associated with lower plaque burden of all subtypes (all p<0.01).

Figure 2.

Figure 2.

Distribution of plaque volumes in relation to FFR by sex

Abbreviations: FFR, fractional flow reserve; CP, calcified plaque; NCP, non-calcified plaque; LD-NCP, low density non-calcified plaque

All p<0.01 for trend in men and women

Table 3.

Plaque burden and impact of female sex

A. Total vessel
Univariable comparison Female Sex in Multivariable linear regression*
Women (n=214) Men (n=367) p-value Coefficient SE p-value
Plaque burden (%)
Total plaque 33.8 (0–46.6) 47.5 (15.8–55.7) <0.001 −0.149 0.053 <0.001
 Calcified plaque 0 (0–5.9) 3.7 (0–10.8) <0.001 −0.115 0.056 0.004
 Non-calcified plaque 26.4 (0–38.8) 38.1 (10.4–46.7) <0.001 −0.131 0.053 <0.001
 Low-density plaque 1.7 (0–4.6) 4.9 (0.8–8.4) <0.001 −0.145 0.044 <0.001
B. Vessel with positive FFR (per-vessel)
Univariable comparison Female Sex in Multivariable linear regression*
Women (n=16) Men (n=123) p-value Coefficient SE p-value
Plaque burden (%)
Total plaque 47.1 (42.9–55.2) 55.3 (48.3–60.0) 0.023 −0.084 0.083 0.330
 Calcified plaque 10.2 (2.1–17.0) 8.5 (3.8–14.4) 0.992 −0.035 0.129 0.680
 Non-calcified plaque 32.9 (27.7–44.7) 43.3 (36.3–53.3) 0.042 −0.061 0.120 0.481
 Low-density plaque 4.0 (2.3–5.7) 8.2 (5.4–11.8) <0.001 −0.183 0.136 0.035

Values are mean standard deviation or number (percentage)

Abbreviations: FFR, fractional flow reserve; SE, standard error

*

Adjustment for coronary artery distribution, stenosis severity and adverse plaque characteristics

In vessels with abnormal FFR, women had lower burdens of total, non-calcified, and low-density non-calcified plaque compared to men (Table 3B, p<0.05). Calcified plaque burden did not differ significantly between men and women (p=0.992). In multivariate analysis with adjustment for stenosis severity, APCs, and coronary artery territory, there was no effect of female sex on the total, calcified, and non-calcified plaque burden. Only low-density non-calcified plaque burden was significantly lower in women (beta: − 0.183, p=0.035). Regarding APCs, overall, 51% of vessels with abnormal FFR had any APCs (71/139 vessels). Women had a lower prevalenceof APCs compared to men in vessels with abnormal FFR (37.5% vs. 52.9%).

In multivariable logistic regression analysis, higher total plaque burden and burdens of all plaque subtypes were associated with abnormal FFR in both men and women (Figure 3, all p <0.05). No significant sex interaction existed between the burdens of all plaque subtypes and abnormal FFR. Table 4 and Supplemental Table 1 show the univariable and multivariable logistic regression analysis to predict abnormal FFR. In multivariable analysis, age, female sex, stenosis severity, number of APCs, and calcified, low-density non0calcified plaque burden were independent predictors of abnormal FFR in both overall vessels and vessels with non-obstructive CAD (Table 4).

Figure 3.

Figure 3.

A. A case example of 68-year-old woman with moderate stenosis (50-69%) and diffuse coronary atherosclerosis in the left anterior descending artery. The fractional flow reserve (FFR) value was 0.76, indicating significant ischemia. Red and yellow overlay depict noncalcified and calcified plaque, respectively. B. In multivariable logistic regression analysis, all types of plaque burden were independently associated with FFR defined ischemia in both women and men. No significant interaction existed between sex and all types of plaque burden for predicting ischemia. *Model adjusted for stenosis severity, adverse plaque characteristics, and coronary artery distribution. Odds ratios for per 5% plaque burden increase.

Tables 4.

Logistic regression for the relationship between clinical and vessel characteristics and fractional flow reserve. in overall (A) and non-obstructive vessels (B).

A. Overall vessels (n=581)
OR 95% CI p-value
Age 0.95 0.92–0.99 0.012
Female 0.38 0.20–0.74 0.005
Hypertension 1.15 1.08–1.23 <0.001
Visual stenosis 2.26 1.72–2.97 <0.001
Number of adverse plaque characteristics 1.91 1.32–2.76 0.001
Calcified plaque burden 1.07 1.04–1.11 <0.001
Low-density plaque burden 1.15 1.08–1.23 <0.001
B. Non-obstructive vessels (<50%, n=391)
Age 0.93 0.88–0.98 0.013
Female 0.07 0.02–0.31 <0.001
Hypertension 2.48 0.95–6.47 0.064
Number of adverse plaque characteristics 3.46 1.80–6.63 <0.001
Calcified plaque burden 1.12 1.05–1.19 <0.001
Low-density plaque burden 1.16 1.02–1.34 0.029

In global chi-square analysis, the addition of quantitative plaque burden improved discriminatory value for the identification of abnormal FFR when added to model with diameter stenosis and APCs in both women (χ2 = 74.75 vs. 58.1, p=0.002, Figure 4A) and men (169.53 vs. 133.87, p<0.001, Figure 4B). In a sub-analysis, quantitative plaque burden provided additive value over diameter stenosis (χ2 values: 64.2 vs. 48.5 in women; 145.7 vs. 103.2 in men, both p<0.05). Adding APCs to the model with diameter stenosis and plaque burden further improved model performance for identifying abnormal FFR (both p<0.05).

Figure 4.

Figure 4.

Additive value of quantitative plaque burden for identifying ischemia in women (A) and men (B) Abbreviations: DSC, diameter stenosis category; APCs, adverse plaque characteristics

4. Discussion

In the current study, we explored the sex differences in CCTA-derived quantitative coronary plaque burden and its association with invasive FFR. We confirmed that women displayed lower stenosis severity, fewer APCs, and lower volumes and burdens of all plaque subtypes compared to men. However, in vessels with abnormal FFR, there was no significant sex interaction in total, calcified, or non-calcified plaque burden. Only low-density non-calcified plaque burden was significantly lower in women in the multivariable analysis. The quantitative assessment of plaque burden by CCTA improved discriminatory performance for ischemia identification in both men and women.

Previous studies have shown that quantitative plaque assessment improved the identification of significant ischemia 10, 11, 13. Nakazato et al. identified that quantitative plaque volume by CCTA was higher in lesions with significant ischemia than lesions without ischemia in patients with intermediate stenosis (30-69%).10 In a study from NXT (coronary blood flow using coronary CT angiography: NeXt sTeps) trial, Gaur et al. reported that low-density non-calcified plaque burden was an independent predictor of lesion-specific ischemia and improved discriminatory power in identifying ischemia-causing lesions 11. Our findings are consistent with these previous reports that higher CCTA-derived quantitative plaque burden was associated with abnormal FFR in men and women.

Sex differences have previously been described in coronary artery plaque burden and distribution. In the 63,215 patients in the CAC consortium, women had less extensive calcified plaque as measured number of lesions and vessels.17 In a study including propensity-matched 525 men and 525 women who underwent CCTA, men had a greater plaque burden than women while women had a larger proportion of mixed and non-calcified plaque components.15 A subanalysis of the SCOT-HEART (Scottish Computed Tomography of the HEART) trial reported that CCTA-derived quantitative plaque burden was significantly lower in women than men.16 Despite these well-known interactions between sex and coronary plaque burden, the potential sex difference of coronary plaque burden in relation to physiologic outcome assessed by FFR has not been previously explored. As expected, the overall plaque burden was significantly lower in women compared to men in the current study. However, in multivariable analysis, vessels with abnormal FFR demonstrated similar total plaque burden and burdens of plaque subtypes between women and men except for low-density non-calcified plaque burden. Low-density non-calcified plaque is a marker of necrotic core 26, 27, which has been shown to be associated with endothelial dysfunction.11, 28 The current results may indicate that the role of the necrotic core in endothelial dysfunction and FFR is more significant in men than in women. On the other hand, there is growing evidence that menopause and estrogen play an important role in the development and progression of atherosclerotic disease in women. Early menopause or lower estrogen level at post-menopause were closely associated with higher atherosclerotic burden, endothelial dysfunction, and coronary microvascular dysfunction2931. Further studies are needed to explore the differences in the relationship between morphological atherosclerotic plaque characteristics and hormonal/endothelial function on ischemia according to sex.

Prior studies reported that significant sex differences existed between stenosis severity and invasive FFR.46 That is, women have been shown to be less likely to have ischemia than men, even having a similar degree of stenosis. We also observed a significantly lower frequency of abnormal ischemia in women among vessels with mild to moderate stenosis. One of the potential explanations for the finding is the sex differences in the coronary volume and myocardial mass (V/M) ratio. A reduced coronary lumen volume to left ventricle mass ratio has been suggested to contribute to impaired coronary blood flow.32 A recent study from the ADVANCE registry revealed that women had a higher V/M ratio which was independently associated with a higher FFR independent of stenosis severity.33 The sex differences in stenosis severity, V/M ratio, and FFR may influence the differences in treatment strategy and prognosis between men and women.4, 34, 35

Since women have less extensive and obstructive and more diffuse CAD compared with men 36, 37, quantitative assessment of plaque burden may be a potential predictive marker of ischemia in addition to stenosis severity. In our analysis, quantitative plaque burden was as strong a predictor of ischemia in women as in men. Further, the addition of quantitative plaque burdens improved discriminatory value for the prediction of ischemia in both women and men. The current study findings show no existing sex interaction in the predictive value of coronary plaque burdens for FFR-defined ischemia; thus, coronary plaque quantification is helpful for the identification of ischemia-causing lesions irrespective of sex.

4.1. Limitations

This study has several limitations. The generalizability of the present findings might be limited by the relatively small sample size from a single center. Furthermore, the frequency of abnormal FFR in women was low (11.5%, 16/214). Further studies are required to confirm the association between plaque burden and FFR according to sex. The cross-sectional nature of this study limits our inference of the potential sex-related differences in the relationship between plaque burden and FFR towards adverse cardiovascular outcomes. Recent evidence indicated that microvascular dysfunction is one of the major causes of ischemic CAD and is highly prevalent in women.38, 39 In the present study, we used FFR as a physiological outcome, assessing only macrovascular flow-limiting lesions.40 The potential sex differences in the relationship between macrovascular plaque burden and microvascular dysfunction warrants further investigation.

5. Conclusion

In this post hoc analysis of a prospective trial including symptomatic patients with suspected CAD, women have a lower CCTA derived burden of all plaque subtypes and fewer abnormal FFR compared to men. Irrespective of sex, CCTA derived quantitative plaque burden provides independent and incremental predictive value for ischemia.

Supplementary Material

1

Acknowledgments

Funding:

This study was supported in part by grants from the National Heart, Lung, and Blood Institute, 1R01HL148787-01A1 and 1R01HL151266. The work is also by a grant from the Miriam and Sheldon G. Adelson Medical Research Foundation.

Abbreviations

FFR

fractional flow reserve

CCTA

Coronary CT angiography

CAD

coronary artery disease

APCs

adverse plaque characteristics

LAD

left anterior descending artery

LCX

left circumflex artery

RCA

right coronary artery

V/M ratio

coronary volume and myocardial mass ratio

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Disclosure: Outside of the current work, S.C., P.S., and D.D. received software royalties from Cedars-Sinai Medical Center. D.B, P.S., and D.D. hold a patent (US8885905B2 in USA and WO patent WO2011069120A1, Method and System for Plaque Characterization).

Outside of the current work, S.C., P.S., and D.D. received software royalties from Cedars-Sinai Medical Center. D.B, P.S., and D.D. hold a patent (US8885905B2 in USA and WO patent WO2011069120A1, Method and System for Plaque Characterization).

All other authors report no conflicts of interest.

References

  • 1.Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek JKJJ JJ. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. The New England journal of medicine. 1996;334:1703–8. [DOI] [PubMed] [Google Scholar]
  • 2.Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’ t Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA and Fearon WF. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. The New England journal of medicine 2009;360:213–24. [DOI] [PubMed] [Google Scholar]
  • 3.De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, Piroth Z, Jagic N, Mobius-Winckler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engström T, Oldroyd K, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Limacher A, Nüesch E and Jüni P. Fractional flow reserve-guided PCI for stable coronary artery disease. The New England journal of medicine 2014;371:1208–17. [DOI] [PubMed] [Google Scholar]
  • 4.Kim HS, Tonino PA, De Bruyne B, Yong AS, Tremmel JA, Pijls NH and Fearon WF. The impact of sex differences on fractional flow reserve-guided percutaneous coronary intervention: a FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) substudy. JACC Cardiovasc Interv 2012;5:1037–42. [DOI] [PubMed] [Google Scholar]
  • 5.Kim CH, Koo BK, Dehbi HM, Lee JM, Doh JH, Nam CW, Shin ES, Cook CM, Al-Lamee R, Petraco R, Sen S, Malik IS, Nijjer SS, Mejía-Rentería H, Alegria-Barrero E, Alghamdi A, Altman J, Baptista SB, Bhindi R, Bojara W, Brugaletta S, Silva PC, Di Mario C, Erglis A, Gerber RT, Going O, Härle T, Hellig F, Indolfi C, Janssens L, Jeremias A, Kharbanda RK, Khashaba A, Kikuta Y, Krackhardt F, Laine M, Lehman SJ, Matsuo H, Meuwissen M, Niccoli G, Piek JJ, Ribichini F, Samady H, Sapontis J, Seto AH, Sezer M, Sharp ASP, Singh J, Takashima H, Talwar S, Tanaka N, Tang K, Van Belle E, van Royen N, Vinhas H, Vrints CJ, Walters D, Yokoi H, Samuels B, Buller C, Patel MR, Serruys PW, Escaned J and Davies JE. Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve-Guided Revascularization Strategy. JACC Cardiovascular interventions 2019;12:2035–2046. [DOI] [PubMed] [Google Scholar]
  • 6.Yonetsu T, Hoshino M, Lee T, Murai T, Sumino Y, Hada M, Yamaguchi M, Kanaji Y, Sugiyama T, Niida T, Matsuda J, Hatano Y, Umemoto T, Sasano T and Kakuta T. Impact of Sex Difference on the Discordance of Revascularization Decision Making Between Fractional Flow Reserve and Diastolic Pressure Ratio During the Wave-Free Period. Journal of the American Heart Association 2020;9:e014790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Dey D, Schepis T, Marwan M, Slomka PJ, Berman DS and Achenbach S. Automated three-dimensional quantification of noncalcified coronary plaque from coronary CT angiography: comparison with intravascular US. Radiology 2010;257:516–22. [DOI] [PubMed] [Google Scholar]
  • 8.Han D, Berman DS, Miller RJH, Andreini D, Budoff MJ, Cademartiri F, Chinnaiyan K, Choi JH, Conte E, Marques H, de Araújo Gonçalves P, Gottlieb I, Hadamitzky M, Leipsic J, Maffei E, Pontone G, Shin S, Kim YJ, Lee BK, Chun EJ, Sung JM, Lee SE, Virmani R, Samady H, Stone P, Narula J, Bax JJ, Shaw LJ, Lin FY, Min JK and Chang HJ. Association of Cardiovascular Disease Risk Factor Burden With Progression of Coronary Atherosclerosis Assessed by Serial Coronary Computed Tomographic Angiography. JAMA network open 2020;3:e2011444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Williams MC, Kwiecinski J, Doris M, McElhinney P, D’Souza MS, Cadet S, Adamson PD, Moss AJ, Alam S, Hunter A, Shah ASV, Mills NL, Pawade T, Wang C, Weir McCall J, Bonnici-Mallia M, Murrills C, Roditi G, van Beek EJR, Shaw LJ, Nicol ED, Berman DS, Slomka PJ, Newby DE, Dweck MR and Dey D. Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART). Circulation 2020;141:1452–1462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Nakazato R, Shalev A, Doh JH, Koo BK, Gransar H, Gomez MJ, Leipsic J, Park HB, Berman DS and Min JK. Aggregate plaque volume by coronary computed tomography angiography is superior and incremental to luminal narrowing for diagnosis of ischemic lesions of intermediate stenosis severity. Journal of the American College of Cardiology 2013;62:460–7. [DOI] [PubMed] [Google Scholar]
  • 11.Gaur S, Øvrehus KA, Dey D, Leipsic J, Bøtker HE, Jensen JM, Narula J, Ahmadi A, Achenbach S, Ko BS, Christiansen EH, Kaltoft AK, Berman DS, Bezerra H, Lassen JF and Nørgaard BL. Coronary plaque quantification and fractional flow reserve by coronary computed tomography angiography identify ischaemia-causing lesions. European heart journal 2016;37:1220–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Dey D, Gaur S, Ovrehus KA, Slomka PJ, Betancur J, Goeller M, Hell MM, Gransar H, Berman DS, Achenbach S, Botker HE, Jensen JM, Lassen JF and Norgaard BL. Integrated prediction of lesion-specific ischaemia from quantitative coronary CT angiography using machine learning: a multicentre study. European radiology 2018;28:2655–2664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Driessen RS, Stuijfzand WJ, Raijmakers PG, Danad I, Min JK, Leipsic JA, Ahmadi A, Narula J, van de Ven PM, Huisman MC, Lammertsma AA, van Rossum AC, van Royen N and Knaapen P. Effect of Plaque Burden and Morphology on Myocardial Blood Flow and Fractional Flow Reserve. Journal of the American College of Cardiology 2018;71:499–509. [DOI] [PubMed] [Google Scholar]
  • 14.Schulman-Marcus J, Hartaigh B, Gransar H, Lin F, Valenti V, Cho I, Berman D, Callister T, DeLago A, Hadamitzky M, Hausleiter J, Al-Mallah M, Budoff M, Kaufmann P, Achenbach S, Raff G, Chinnaiyan K, Cademartiri F, Maffei E, Villines T, Kim YJ, Leipsic J, Feuchtner G, Rubinshtein R, Pontone G, Andreini D, Marques H, Shaw L and Min JK. Sex-Specific Associations Between Coronary Artery Plaque Extent and Risk of Major Adverse Cardiovascular Events: The CONFIRM Long-Term Registry. JACC Cardiovascular imaging 2016;9:364–372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Plank F, Beyer C, Friedrich G, Wildauer M and Feuchtner G. Sex differences in coronary artery plaque composition detected by coronary computed tomography: quantitative and qualitative analysis. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2019;27:272–280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Williams MC, Kwiecinski J, Doris M, McElhinney P, D’Souza MS, Cadet S, Adamson PD, Moss AJ, Alam S, Hunter A, Shah ASV, Mills NL, Pawade T, Wang C, Weir-McCall JR, Bonnici-Mallia M, Murrills C, Roditi G, van Beek EJR, Shaw LJ, Nicol ED, Berman DS, Slomka PJ, Newby DE, Dweck MR and Dey D. Sex-Specific Computed Tomography Coronary Plaque Characterization and Risk of Myocardial Infarction. JACC Cardiovascular imaging 2021;14:1804–1814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Shaw LJ, Min JK, Nasir K, Xie JX, Berman DS, Miedema MD, Whelton SP, Dardari ZA, Rozanski A, Rumberger J, Bairey Merz CN, Al-Mallah MH, Budoff MJ and Blaha MJ. Sex differences in calcified plaque and long-term cardiovascular mortality: observations from the CAC Consortium. European heart journal 2018;39:3727–3735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Shaw LJ, Min JK, Narula J, Lin F, Bairey-Merz CN, Callister TQ and Berman DS. Sex differences in mortality associated with computed tomographic angiographic measurements of obstructive and nonobstructive coronary artery disease: an exploratory analysis. Circulation Cardiovascular imaging 2010;3:473–81. [DOI] [PubMed] [Google Scholar]
  • 19.Danad I, Raijmakers PG, Driessen RS, Leipsic J, Raju R, Naoum C, Knuuti J, Mäki M, Underwood RS, Min JK, Elmore K, Stuijfzand WJ, van Royen N, Tulevski, II, Somsen AG, Huisman MC, van Lingen AA, Heymans MW, van de Ven PM, van Kuijk C, Lammertsma AA, van Rossum AC and Knaapen P. Comparison of Coronary CT Angiography, SPECT, PET, and Hybrid Imaging for Diagnosis of Ischemic Heart Disease Determined by Fractional Flow Reserve. JAMA cardiology 2017;2:1100–1107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Motoyama S, Kondo T, Sarai M, Sugiura A, Harigaya H, Sato T, Inoue K, Okumura M, Ishii J, Anno H, Virmani R, Ozaki Y, Hishida H and Narula J. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. Journal of the American College of Cardiology 2007;50:319–26. [DOI] [PubMed] [Google Scholar]
  • 21.Maurovich-Horvat P, Hoffmann U, Vorpahl M, Nakano M, Virmani R and Alkadhi H. The napkinring sign: CT signature of high-risk coronary plaques? JACC Cardiovascular imaging. 2010;3:440–4. [DOI] [PubMed] [Google Scholar]
  • 22.Motoyama S, Sarai M, Harigaya H, Anno H, Inoue K, Hara T, Naruse H, Ishii J, Hishida H, Wong ND, Virmani R, Kondo T, Ozaki Y and Narula J. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. Journal of the American College of Cardiology 2009;54:49–57. [DOI] [PubMed] [Google Scholar]
  • 23.Dey D, Cheng VY, Slomka PJ, Nakazato R, Ramesh A, Gurudevan S, Germano G and Berman DS. Automated 3-dimensional quantification of noncalcified and calcified coronary plaque from coronary CT angiography. Journal of cardiovascular computed tomography 2009;3:372–82. [DOI] [PubMed] [Google Scholar]
  • 24.Bashore TM, Balter S, Barac A, Byrne JG, Cavendish JJ, Chambers CE, Hermiller JB Jr., Kinlay S, Landzberg JS, Laskey WK, McKay CR, Miller JM, Moliterno DJ, Moore JW, Oliver-McNeil SM, Popma JJ and Tommaso CL. 2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: A report of the American College of Cardiology Foundation Task Force on Expert Consensus documents developed in collaboration with the Society of Thoracic Surgeons and Society for Vascular Medicine. Journal of the American College of Cardiology 2012;59:2221–305. [DOI] [PubMed] [Google Scholar]
  • 25.Vickers AJ, Cronin AM and Begg CB. One statistical test is sufficient for assessing new predictive markers. BMC medical research methodology 2011;11:13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Han D, Torii S, Yahagi K, Lin FY, Lee JH, Rizvi A, Gransar H, Park MW, Roudsari HM, Stuijfzand WJ, Baskaran L, B ÓH, Park HB, Lee SE, Ali Z, Kutys R, Chang HJ, Earls JP, Fowler D, Virmani R and Min JK. Quantitative measurement of lipid rich plaque by coronary computed tomography angiography: A correlation of histology in sudden cardiac death. Atherosclerosis 2018;275:426–433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Abdelrahman KM, Chen MY, Dey AK, Virmani R, Finn AV, Khamis RY, Choi AD, Min JK, Williams MC, Buckler AJ, Taylor CA, Rogers C, Samady H, Antoniades C, Shaw LJ, Budoff MJ, Hoffmann U, Blankstein R, Narula J and Mehta NN. Coronary Computed Tomography Angiography From Clinical Uses to Emerging Technologies: JACC State-of-the-Art Review. Journal of the American College of Cardiology 2020;76:1226–1243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Han D, Starikov A, B ÓH, Gransar H, Kolli KK, Lee JH, Rizvi A, Baskaran L, Schulman-Marcus J, Lin FY and Min JK. Relationship Between Endothelial Wall Shear Stress and High-Risk Atherosclerotic Plaque Characteristics for Identification of Coronary Lesions That Cause Ischemia: A Direct Comparison With Fractional Flow Reserve. Journal of the American Heart Association 2016;5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Muka T, Oliver-Williams C, Kunutsor S, Laven JS, Fauser BC, Chowdhury R, Kavousi M and Franco OH. Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis. JAMA Cardiol 2016;1:767–776. [DOI] [PubMed] [Google Scholar]
  • 30.Oliver-Williams C, Glisic M, Shahzad S, Brown E, Pellegrino Baena C, Chadni M, Chowdhury R, Franco OH and Muka T. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review. Hum Reprod Update 2019;25:257–271. [DOI] [PubMed] [Google Scholar]
  • 31.Gilligan DM, Quyyumi AA and Cannon RO 3rd. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994;89:2545–51. [DOI] [PubMed] [Google Scholar]
  • 32.van Diemen PA, Schumacher SP, Bom MJ, Driessen RS, Everaars H, Stuijfzand WJ, Raijmakers PG, van de Ven PM, Min JK, Leipsic JA, Knuuti J, Boellaard PR, Taylor CA, van Rossum AC, Danad I and Knaapen P. The association of coronary lumen volume to left ventricle mass ratio with myocardial blood flow and fractional flow reserve. J Cardiovasc Comput Tomogr 2019;13:179–187. [DOI] [PubMed] [Google Scholar]
  • 33.Fairbairn TA, Dobson R, Hurwitz-Koweek L, Matsuo H, Norgaard BL, Rønnow Sand NP, Nieman K, Bax JJ, Pontone G, Raff G, Chinnaiyan KM, Rabbat M, Amano T, Kawasaki T, Akasaka T, Kitabata H, Binukrishnan S, Rogers C, Berman D, Patel MR, Douglas PS and Leipsic J. Sex Differences in Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve: Lessons From ADVANCE. JACC Cardiovascular imaging 2020;13:2576–2587. [DOI] [PubMed] [Google Scholar]
  • 34.Huckaby LV, Seese LM, Sultan I, Gleason TG, Wang Y, Thoma F and Kilic A. The Impact of Sex on Outcomes After Revascularization for Multivessel Coronary Disease. Ann Thorac Surg 2020;110:1243–1250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Gaudino M, Di Franco A, Alexander JH, Bakaeen F, Egorova N, Kurlansky P, Boening A, Chikwe J, Demetres M, Devereaux PJ, Diegeler A, Dimagli A, Flather M, Hameed I, Lamy A, Lawton JS, Reents W, Robinson NB, Audisio K, Rahouma M, Serruys PW, Hara H, Taggart DP, Girardi LN, Fremes SE and Benedetto U. Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data. European heart journal 2021;43:18–28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Van de Werf F, Aylward P, Topol EJ and Califf RM. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. The New England journal of medicine 1999;341:226–32. [DOI] [PubMed] [Google Scholar]
  • 37.Shaw LJ, Bugiardini R and Merz CN. Women and ischemic heart disease: evolving knowledge. Journal of the American College of Cardiology 2009;54:1561–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Wei J, Mehta PK, Johnson BD, Samuels B, Kar S, Anderson RD, Azarbal B, Petersen J, Sharaf B, Handberg E, Shufelt C, Kothawade K, Sopko G, Lerman A, Shaw L, Kelsey SF, Pepine CJ and Merz CN. Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women’s Ischemia Syndrome Evaluation) study. JACC Cardiovascular interventions 2012;5:646–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Garcia M, Mulvagh SL, Merz CN, Buring JE and Manson JE. Cardiovascular Disease in Women: Clinical Perspectives. Circulation research 2016;118:1273–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.De Bruyne B, Oldroyd KG and Pijls NHJ. Microvascular (Dys)Function and Clinical Outcome in Stable Coronary Disease. Journal of the American College of Cardiology 2016;67:1170–1172. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES